CIBC Asset Management
BIVV

CIBC Asset Management’s Bioverativ Inc. Common Stock BIVV Stock Holding History

CIBC Asset Management’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-4,885
Closed -$263K – 1100
2017
Q4 		$263K Sell
4,885
-61
-1% -$3.34K ﹤0.01% 865
2017
Q3 		$282K Buy
4,946
+207
+4% +$12.1K ﹤0.01% 823
2017
Q2 		$285K Sell
4,739
-95
-2% -$5.41K ﹤0.01% 800
2017
Q1 		$263K Buy
+4,834
New +$238K ﹤0.01% 817

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

CIBC Asset Management's BIVV Position: Q1 2018 in Review

CIBC Asset Management sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 4,885 shares — an estimated $263K sold.

CIBC Asset Management first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $285K in Q2 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • CIBC Asset Management reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • CIBC Asset Management sold 4,885 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $263K.
  • CIBC Asset Management first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
  • CIBC Asset Management's Bioverativ Inc. Common Stock position peaked at $285K in Q2 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on CIBC Asset Management's 13F filing for Q1 2018, filed 30 Apr 2018.